Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Mandelli

Showing results (481-490 of 573) with videos related to

Pageof 58
Sort By:
Leukemia|January 1, 1991
Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alfa levels are significantly increased in acute myeloid leukemia patientsG Cimino, S Amadori, M C Cava, et al.
British Journal of Haematology|November 28, 2001
Prolonged molecular remission in advanced acute promyelocytic leukaemia after treatment with gemtuzumab ozogamicin (Mylotarg CMA-676)M C Petti, M B Pinazzi, D Diverio, et al.
Haematologica|May 1, 1989
Intensification in post-remission treatment of adult acute non lymphocytic leukemiaM C Petti, M A Aloe Spiriti, A M Carella, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 21, 2001
A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropeniaA Del Favero, F Menichetti, P Martino, et al.
Haematologica|December 24, 1997
A single high dose of idarubicin combined with high-dose ABA-C (MSKCC ALL-3 protocol) in adult and pediatric patients with acute lymphoblastic leukemia. Experience at the University La Sapienza of RomeA M Testi, M L Moleti, F Giona, et al.
European Journal of Haematology. Supplementum|January 1, 1990
Alpha-2b-interferon as single therapy for patients with chronic myeloid leukemia relapsing after T-cell depleted allogeneic bone marrow transplantationW Arcese, F R Mauro, M Screnci, et al.
British Journal of Haematology|May 31, 2001
Reduced susceptibility to apoptosis correlates with kinetic quiescence in disease progression of chronic lymphocytic leukaemiaM R Ricciardi, M T Petrucci, C Gregorj, et al.
British Journal of Haematology|May 1, 1981
Factor VII deficiency: immunological characterization of genetic variants and detection of carriersG Mariani, M G Mazzucconi, J Hermans, et al.
British Journal of Haematology|August 12, 1999
Flt3LP3nduces the ex-vivo amplification of umbilical cord blood committed progenitors and early stem cells in short-term culturesL De Felice, T Di Pucchio, M G Mascolo, et al.
Leukemia|August 26, 2006
Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular featuresM Breccia, G Avvisati, R Latagliata, et al.
Pageof 58

Showing results (481-490 of 573) with videos related to

Sort By:
Pageof 58
Leukemia|January 1, 1991
Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alfa levels are significantly increased in acute myeloid leukemia patientsG Cimino, S Amadori, M C Cava, et al.
British Journal of Haematology|November 28, 2001
Prolonged molecular remission in advanced acute promyelocytic leukaemia after treatment with gemtuzumab ozogamicin (Mylotarg CMA-676)M C Petti, M B Pinazzi, D Diverio, et al.
Haematologica|May 1, 1989
Intensification in post-remission treatment of adult acute non lymphocytic leukemiaM C Petti, M A Aloe Spiriti, A M Carella, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 21, 2001
A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropeniaA Del Favero, F Menichetti, P Martino, et al.
Haematologica|December 24, 1997
A single high dose of idarubicin combined with high-dose ABA-C (MSKCC ALL-3 protocol) in adult and pediatric patients with acute lymphoblastic leukemia. Experience at the University La Sapienza of RomeA M Testi, M L Moleti, F Giona, et al.
European Journal of Haematology. Supplementum|January 1, 1990
Alpha-2b-interferon as single therapy for patients with chronic myeloid leukemia relapsing after T-cell depleted allogeneic bone marrow transplantationW Arcese, F R Mauro, M Screnci, et al.
British Journal of Haematology|May 31, 2001
Reduced susceptibility to apoptosis correlates with kinetic quiescence in disease progression of chronic lymphocytic leukaemiaM R Ricciardi, M T Petrucci, C Gregorj, et al.
British Journal of Haematology|May 1, 1981
Factor VII deficiency: immunological characterization of genetic variants and detection of carriersG Mariani, M G Mazzucconi, J Hermans, et al.
British Journal of Haematology|August 12, 1999
Flt3LP3nduces the ex-vivo amplification of umbilical cord blood committed progenitors and early stem cells in short-term culturesL De Felice, T Di Pucchio, M G Mascolo, et al.
Leukemia|August 26, 2006
Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular featuresM Breccia, G Avvisati, R Latagliata, et al.
Pageof 58